Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer’s disease model - Top-Institutions - MDSpire

Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer’s disease model

  • By

  • Juan Zu

  • Cong Li

  • Mochen Cui

  • Xinwu Liu

  • Zhouyang Pan

  • Xiaohe Li

  • Fang Zhang

  • Johanna Gentz

  • Gerda Mitteregger-Kretzschmar

  • Jochen Herms

  • Yuan Shi

  • December 15, 2025

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Neuroscience
    • Neuroimmunology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neuroscience
    • Immunology

  • #3

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurodegeneration
    • Molecular Biology

  • #4

    Washington University in St. Louis
    Washington University in St. Louis

    St. Louis, MO

    Key Differentiators

    • Neurology
    • Neuroscience
    • Immunology

Original Source(s)

Pioglitazone attenuates complement-mediated microglial synaptic engulfment in an Alzheimer’s disease model

  • by Juan Zu, Cong Li, Mochen Cui, Xinwu Liu, Zhouyang Pan, Xiaohe Li, Fang Zhang, Johanna Gentz, Gerda Mitteregger-Kretzschmar, Jochen Herms, Yuan Shi

  • December 15, 2025

Related Content

Cognitive Trajectories and Subsequent Accelerometer-Measured Movement Behavior in Older Adults

Editorial: Transforming neurological recovery: the promise of regenerative neurorehabilitation

The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease